Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To investigate the role of Heat Shock Proteins in the mechanism of acute severe pancreatitis. In addition to test the potential treatment target of acute pancreatitis.
All patients who present with clinical symptoms of acute pancreatitis are evaluated for the enrollment of the study.
All patients with acute pancreatitis are evaluated according to modified Atlanta classification acute pancreatitis severity scores.
Blood serum, urine and DNA samples are collected from all patients presented on admission, after 24 hours, 48 hours, 72 hours.
CT is performed in al patients to evaluate necrosis of pancreas Day 5-7 since hospital admission. If necrosis is not present follow-up is stopped.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Acute pancreatitis | First time acute pancreatitis. No later than 2 days since the clinical symptoms started. |
| |
| Healthy | No major systemic illness |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CT Scan Day 5-7 | Diagnostic Test | Computed Tomography on Day 5-7 according to a clinical protocol. |
|
| Measure | Description | Time Frame |
|---|---|---|
| To measure the levels of heat shock proteins in serum and plasma in acute severe pancreatitis settings | Different molecular weight Heat Shock proteins role while developing acute pancreatitis. | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| To measure pancreas cells activity while applying Heat Shock Protein inhibitors | To establish a mechanism explaining the potential use of heat shock proteins inhibitors/ activators for treatment of acute pancreatitis | 2 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients admitted to the hospital within 48 hours since the typical symptoms of acute pancreatitis
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Kestutis Strupas, Prof. MD/PhD | Contact | +37052365000 | kestutis.strupas@santa.lt | |
| Aiste Gulla, MD | Contact | +37052365000 | aiste.kielaite-gulla@santa.lt |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vilnius University Hospital "Santaros Klinikos | Recruiting | Vilnius | 08410 | Lithuania |
We plan to share the data and recruitment status when the study reaches its requirement sample size
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010195 | Pancreatitis |
| D004194 | Disease |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood and urine samples on admission